<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04998968</url>
  </required_header>
  <id_info>
    <org_study_id>2021-01997</org_study_id>
    <nct_id>NCT04998968</nct_id>
  </id_info>
  <brief_title>Quality in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy</brief_title>
  <official_title>Quality of Life in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy in a Swedish Population Based Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uppsala University</source>
  <brief_summary>
    <textblock>
      Quality of life study. The study with include all patients operated with total thyroidectomy&#xD;
      between 2005-2015 in Uppsala-Örebro healthcare region, Sweden. The study population has been&#xD;
      identified in a previous study and includes close to 1700 patients, of which about 200&#xD;
      developed permanent hypoparathyroidism after surgery.&#xD;
&#xD;
      Quality of Life will be assessed using SF-36 Health Surgery and the outcome for patients with&#xD;
      and without permanent hypoparathyroidism will be compared.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Life using SF-36 short form</measure>
    <time_frame>2021</time_frame>
    <description>The SF-36 yields eight scale scores and two summary scores, the physical component summary (PCS) and mental component summary (MCS). Scoring PCS and MCS involves three steps: 1) standardization of the scales (z-scores) 2) aggregation of score scales and 3) transformation of summary scores (t-scores). For each domain (PCS and MCS) the mean score is 50 with a standard deviation of 10. Higher scores indicates better quality of life (score range 0-100)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1700</enrollment>
  <condition>Permanent Hypoparathyroidism</condition>
  <arm_group>
    <arm_group_label>Patients with permanent hypoparathyroidism after total thyroidectomy</arm_group_label>
    <description>Patients with permanent hypoparathyroidism after total thyroidectomy for benign thyroid disease. These patients should be operated between 2005-2015 in Uppsala-Örebro healthcare region. Permanent hypoparathyroidism is defined as treatment with Calcium and/or vitamin D more than 12 months after surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without permanent hypoparathyroidism after total thyroidectomy</arm_group_label>
    <description>Patients without permanent hypoparathyroidism after total thyroidectomy for benign thyroid disease. These patients should be operated between 2005-2015 in Uppsala-Örebro healthcare region.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The patients are identified through the national quality registry for endocrine surgery,&#xD;
        SQRTPA and the Swedish National Patient Register&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Total thyroidectomy between 2005-2015 in Uppsala-Orebro healthcare region.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Malignancy&#xD;
&#xD;
          -  Sternotomy&#xD;
&#xD;
          -  Previous thyroid surgery&#xD;
&#xD;
          -  Previous or concurrent parathyroidectomy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olov Norlén, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uppsala University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 9, 2021</study_first_submitted>
  <study_first_submitted_qc>August 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoparathyroidism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

